Corindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, filed on Monday with the SEC to raise up to $40 million in a US public offering. The stock currently trades on the OTCQB under the symbol CVRS and has a market cap of about $450 million.
The Waltham, MA-based company, which was founded in 2011 and booked $3 million in sales for the 12 months ended December 31, 2014, plans to list on the NYSE under the symbol CVRS. Cowen & Company and Stifel are the joint bookrunners on the deal. No pricing terms were disclosed.
